Specialty Development Executive, Clinical Specialist - Orlando, Jacksonville, Tallahassee
Labcorp2 days ago
Highlight
OnsiteFull-timeMid
Summary
Labcorp is seeking a Specialty Development Executive, Clinical Specialist to join their team covering the Orlando, Jacksonville, and Tallahassee territory. The role focuses on growing and retaining business in specialty segments such as Ambulatory Surgery Centers, Dermatology, and more.
About the Role
As a Specialty Development Executive, you will function as an outside sales representative, responsible for maintaining an annual book of business, achieving sales growth goals, and serving as a subject matter expert on Labcorp's testing solutions. You will create effective customer relationships, collaborate with internal teams, and stay updated on industry trends to identify new business opportunities.
About You
Required:
- High School Diploma or GED required; Bachelor's degree preferred.
- Previous sales experience or account management required, preferably 5 years.
- Experience selling Clinical / Pathology lab testing.
- Strong degree of comfort in both inpatient and outpatient settings.
Preferred:
- Successful experience in the AP or clinical specialties space.
- Strong technical competency and business acumen capabilities.
Benefits
- Comprehensive benefits including Medical, Dental, Vision, Life, STD/LTD, 401(k), Paid Time Off (PTO) or Flexible Time Off (FTO), Tuition Reimbursement, and Employee Stock Purchase Plan.
Labcorp
Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about Labcorp (NYSE: LH) at www.labcorp.com.
Jacksonville, FL